Literature DB >> 29948131

Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms.

Irene Lambrinoudaki1, Panagiota Chatzivasileiou2, Stefanos Stergiotis2, Eleni Armeni2, Dimitrios Rizos3, George Kaparos3, Areti Augoulea2, Andreas Alexandrou2, Georgios Georgiopoulos4, Aggeliki Laina4, Kimon Stamatelopoulos4.   

Abstract

Genetic variations of genes encoding the endothelial nitric oxide synthase (eNOS) and the NADH/NADPH oxidase system are related with atherosclerosis in the general population, but their significance in women is not sufficiently assessed. We investigated the potential association between the G894T polymorphism of the NOS3 gene and the C242T polymorphism of the CYBA gene with subclinical vascular disease. Seventy (70) healthy, normally ovulating, premenopausal women were recruited for this study. Venous blood samples were obtained for biochemical/hormonal assessment as well as for genotyping, using real-time PCR. Sonographically assessed indices of vascular structure and function included carotid and femoral intima-media thickness (IMT), flow-mediated dilation (FMD), carotid-femoral pulse-wave velocity (PWV), and augmentation index. The prevalence of wild type, heterozygote, and homozygote genotype was 44.3% (31/70), 54.3% (38/70), and 1.4% (1/70) for the G894T polymorphism and 38.6% (27/70), 31.4% (22/70), and 30.0% (21/70) for the C242T polymorphism, respectively. After multivariable adjustment, the hC242T polymorphism was a predictor of both internal carotid IMT (b-coefficient - 0.119, p = 0.011) and combined-IMT (b-coefficient - 0.061, p = 0.015). Systolic blood pressure, lipids, and hC242T determined values of FMD (b-coefficient - 1.604, p = 0.034). Concerning the NOS3 G894T polymorphism, carriers of the polymorphic variant had higher values of IMT and PWV compared to the wild-type subgroup (carotid bulb-IMT and PWV, heterozygotes/homozygotes vs wild type 0.7 ± 0.2 vs 0.6 ± 0.1 mm; 7.1 ± 0.8 vs 6.6 ± 0.7 m/s; p = 0.048 and p = 0.029, respectively). These differences, however, were rendered non-significant in the multivariable analysis. In healthy premenopausal women, the CYBA C242T polymorphism is an independent determinant of endothelial function and subclinical atherosclerosis of the carotid arteries. The NOS3 G894T polymorphic variant also correlated with atherosclerosis, an association probably mediated by the traditional risk factors for CVD. The relevance of these findings in the clinical setting remains to be elucidated.

Entities:  

Keywords:  CYBA C242T polymorphism; NOS3 G894T polymorphism; Premenopausal women; Subclinical atherosclerosis; Vascular stiffness

Mesh:

Substances:

Year:  2018        PMID: 29948131     DOI: 10.1007/s00380-018-1198-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  34 in total

Review 1.  Estrogen modulation of endothelial nitric oxide synthase.

Authors:  Ken L Chambliss; Philip W Shaul
Journal:  Endocr Rev       Date:  2002-10       Impact factor: 19.871

Review 2.  Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease.

Authors:  Jennifer Streeter; William Thiel; Kate Brieger; Francis J Miller
Journal:  Cardiovasc Ther       Date:  2012-01-26       Impact factor: 3.023

Review 3.  Predictors of cardiovascular risk in women.

Authors:  Tamer Sallam; Karol E Watson
Journal:  Womens Health (Lond)       Date:  2013-09

4.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease.

Authors:  N Inoue; S Kawashima; K Kanazawa; S Yamada; H Akita; M Yokoyama
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

5.  C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension.

Authors:  Adnan Rafiq; Khursheed Aslam; Rouf Malik; Dil Afroze
Journal:  Mol Med Rep       Date:  2014-02-26       Impact factor: 2.952

6.  The interaction of endothelial nitric oxide synthase polymorphism and current smoking in terms of increased arterial stiffness.

Authors:  O Mayer; J Filipovský; M Pesta; R Cífková; M Dolejsová; J Simon
Journal:  Physiol Res       Date:  2009-11-20       Impact factor: 1.881

7.  CYBA C242T gene polymorphism and flow-mediated vasodilation in a population of young adults: the Cardiovascular Risk in Young Finns Study.

Authors:  Meng Fan; Olli T Raitakari; Mika Kähönen; Markus Juonala; Nina Hutri-Kähönen; Jukka Marniemi; Riikka Rontu; Ilkka Pörsti; Jorma Viikari; Terho Lehtimäki
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

Review 8.  Menopause and cardiovascular disease: the evidence.

Authors:  G M C Rosano; C Vitale; G Marazzi; M Volterrani
Journal:  Climacteric       Date:  2007-02       Impact factor: 3.005

Review 9.  NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases.

Authors:  Gorka San José; Ana Fortuño; Oscar Beloqui; Javier Díez; Guillermo Zalba
Journal:  Clin Sci (Lond)       Date:  2008-02       Impact factor: 6.124

10.  NADPH oxidase p22phox C242T polymorphism and ischemic cerebrovascular disease: an updated meta-analysis.

Authors:  Pingping Li; Tangmeng Qiu; Chao Qin
Journal:  Med Sci Monit       Date:  2015-01-19
View more
  1 in total

1.  NADPH Oxidase Gene Polymorphism is Associated with Mortality and Cardiovascular Events in 7-Year Follow-Up.

Authors:  Milena Racis; Wojciech Sobiczewski; Anna Stanisławska-Sachadyn; Marcin Wirtwein; Elżbieta Bluj; Michał Nedoszytko; Joanna Borzyszkowska; Janusz Limon; Andrzej Rynkiewicz; Marcin Gruchała
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.